Evaluation of the endocrine disrupting potential of Di-isodecyl phthalate
Low molecular weight ortho-phthalates have been implicated in perturbing androgen pathways when administered during the masculinization programming window. Di-isodecyl phthalate (DIDP) is a high molecular weight phthalate and as a high production volume chemical, its ability to disrupt endocrine pat...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Current Research in Toxicology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666027X25000076 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849472196547706880 |
|---|---|
| author | I.A. Lea D. Feifarek A. Mihalchik M. Heintz L. Haws H. Nyambego K. Goyak C. Palermo S.J. Borghoff |
| author_facet | I.A. Lea D. Feifarek A. Mihalchik M. Heintz L. Haws H. Nyambego K. Goyak C. Palermo S.J. Borghoff |
| author_sort | I.A. Lea |
| collection | DOAJ |
| description | Low molecular weight ortho-phthalates have been implicated in perturbing androgen pathways when administered during the masculinization programming window. Di-isodecyl phthalate (DIDP) is a high molecular weight phthalate and as a high production volume chemical, its ability to disrupt endocrine pathways is important to understand its potential hazard. Both DIDP (and its metabolites) were evaluated to determine the potential to perturb endocrine pathways through a weight of evidence (WoE) assessment in accordance with the European Chemicals Agency (ECHA)/European Food Safety Authority (EFSA) Endocrine Disruptor Guidance (2018). A literature review was performed of toxicological data for DIDP related to estrogen, androgen, thyroid, or steroidogenesis pathways. Literature searches returned 41 relevant articles from which data were extracted and assessed in conjunction with data from 105 high-throughput assays. Because some of the in vitro assays lack metabolic capabilities, an in silico assessment of estrogen (E), androgen (A), thyroid (T) or steroidogenesis (S) activity was conducted. Based on the available evidence for the T pathway, DIDP did not elicit adverse thyroid outcomes in vivo. When considering the T mechanistic data, there was evidence that DIDP induced the liver pregnane X receptor (PXR) and some indication that DIDP increased iodide uptake in the thyroid. As there were no studies evaluating thyroid hormone levels in vivo, a data gap was identified because per the ECHA/EFSA guidance, the lack of this information prevents drawing a conclusion on the T pathway. However, the E, A and S pathways were sufficiently assessed to conclude a limited or lack of E, A or S related apical outcomes in in vivo studies; there was also a lack of endocrine activity in in vitro or in vivo mechanistic studies. These results suggest that DIDP does not meet the ECHA/EFSA criteria for an endocrine disruptor, therefore DIDP is unlikely to disrupt the androgen pathway during development. |
| format | Article |
| id | doaj-art-6dcd54f4957e48678f5709aa7ccbfcd4 |
| institution | Kabale University |
| issn | 2666-027X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Current Research in Toxicology |
| spelling | doaj-art-6dcd54f4957e48678f5709aa7ccbfcd42025-08-20T03:24:36ZengElsevierCurrent Research in Toxicology2666-027X2025-01-01810022110.1016/j.crtox.2025.100221Evaluation of the endocrine disrupting potential of Di-isodecyl phthalateI.A. Lea0D. Feifarek1A. Mihalchik2M. Heintz3L. Haws4H. Nyambego5K. Goyak6C. Palermo7S.J. Borghoff8ToxStrategies LLC, 31 College Place Suite B118, Asheville, NC 28801, USA; Corresponding author.ToxStrategies LLC, 31 College Place Suite B118, Asheville, NC 28801, USAToxStrategies LLC, 31 College Place Suite B118, Asheville, NC 28801, USAToxStrategies LLC, 31 College Place Suite B118, Asheville, NC 28801, USAToxStrategies LLC, 31 College Place Suite B118, Asheville, NC 28801, USAExxonMobil Biomedical Sciences, Inc., Health and Environmental Sciences Division, Annandale, NJ, USAExxonMobil Biomedical Sciences, Inc., Health and Environmental Sciences Division, Annandale, NJ, USAExxonMobil Biomedical Sciences, Inc., Health and Environmental Sciences Division, Annandale, NJ, USAToxStrategies LLC, 31 College Place Suite B118, Asheville, NC 28801, USALow molecular weight ortho-phthalates have been implicated in perturbing androgen pathways when administered during the masculinization programming window. Di-isodecyl phthalate (DIDP) is a high molecular weight phthalate and as a high production volume chemical, its ability to disrupt endocrine pathways is important to understand its potential hazard. Both DIDP (and its metabolites) were evaluated to determine the potential to perturb endocrine pathways through a weight of evidence (WoE) assessment in accordance with the European Chemicals Agency (ECHA)/European Food Safety Authority (EFSA) Endocrine Disruptor Guidance (2018). A literature review was performed of toxicological data for DIDP related to estrogen, androgen, thyroid, or steroidogenesis pathways. Literature searches returned 41 relevant articles from which data were extracted and assessed in conjunction with data from 105 high-throughput assays. Because some of the in vitro assays lack metabolic capabilities, an in silico assessment of estrogen (E), androgen (A), thyroid (T) or steroidogenesis (S) activity was conducted. Based on the available evidence for the T pathway, DIDP did not elicit adverse thyroid outcomes in vivo. When considering the T mechanistic data, there was evidence that DIDP induced the liver pregnane X receptor (PXR) and some indication that DIDP increased iodide uptake in the thyroid. As there were no studies evaluating thyroid hormone levels in vivo, a data gap was identified because per the ECHA/EFSA guidance, the lack of this information prevents drawing a conclusion on the T pathway. However, the E, A and S pathways were sufficiently assessed to conclude a limited or lack of E, A or S related apical outcomes in in vivo studies; there was also a lack of endocrine activity in in vitro or in vivo mechanistic studies. These results suggest that DIDP does not meet the ECHA/EFSA criteria for an endocrine disruptor, therefore DIDP is unlikely to disrupt the androgen pathway during development.http://www.sciencedirect.com/science/article/pii/S2666027X25000076Di-isodecyl phthalateDIDPEndocrine disruptionHazard identificationWeight of evidenceEstrogen |
| spellingShingle | I.A. Lea D. Feifarek A. Mihalchik M. Heintz L. Haws H. Nyambego K. Goyak C. Palermo S.J. Borghoff Evaluation of the endocrine disrupting potential of Di-isodecyl phthalate Current Research in Toxicology Di-isodecyl phthalate DIDP Endocrine disruption Hazard identification Weight of evidence Estrogen |
| title | Evaluation of the endocrine disrupting potential of Di-isodecyl phthalate |
| title_full | Evaluation of the endocrine disrupting potential of Di-isodecyl phthalate |
| title_fullStr | Evaluation of the endocrine disrupting potential of Di-isodecyl phthalate |
| title_full_unstemmed | Evaluation of the endocrine disrupting potential of Di-isodecyl phthalate |
| title_short | Evaluation of the endocrine disrupting potential of Di-isodecyl phthalate |
| title_sort | evaluation of the endocrine disrupting potential of di isodecyl phthalate |
| topic | Di-isodecyl phthalate DIDP Endocrine disruption Hazard identification Weight of evidence Estrogen |
| url | http://www.sciencedirect.com/science/article/pii/S2666027X25000076 |
| work_keys_str_mv | AT ialea evaluationoftheendocrinedisruptingpotentialofdiisodecylphthalate AT dfeifarek evaluationoftheendocrinedisruptingpotentialofdiisodecylphthalate AT amihalchik evaluationoftheendocrinedisruptingpotentialofdiisodecylphthalate AT mheintz evaluationoftheendocrinedisruptingpotentialofdiisodecylphthalate AT lhaws evaluationoftheendocrinedisruptingpotentialofdiisodecylphthalate AT hnyambego evaluationoftheendocrinedisruptingpotentialofdiisodecylphthalate AT kgoyak evaluationoftheendocrinedisruptingpotentialofdiisodecylphthalate AT cpalermo evaluationoftheendocrinedisruptingpotentialofdiisodecylphthalate AT sjborghoff evaluationoftheendocrinedisruptingpotentialofdiisodecylphthalate |